The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

The synthetic additive found in thousands of food products will now be phased out by 2027, but advocates say the agency's ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

During Donald Trump's draconian first-week rollbacks, cancer research and other crucial medical projects have been paused ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...

The FDA issued a ban on the use of red dye No. 3 in food and beverage products and ingested drugs. The synthetic dye has been ...

Studies going back decades have shown a potential link between artificial food dyes and attention deficit hyperactivity ...

Zentalis Pharmaceuticals said it would cut 40% of its workforce as part of a restructuring to support the late-stage development of its cancer-drug azenosertib.

Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.